OMBP Insider Trading Activity and SEC Form 4 Filings
OMBP insider trading summary
No open-market insider purchases or sales of Omni Bio Pharmaceutical, Inc. (OMBP) have been reported on SEC Form 4 in the past 12 months.
Latest OMBP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 27, 2015 | BOCO Investments LLC | 10% Owner | Buy | $750K (2,998,678 @ $0.25) |
| Feb 27, 2015 | BOCO Investments LLC | 10% Owner | Buy | $30K (3,000,000 @ $0.01) |
| May 30, 2013 | BOCO Investments LLC | 10% Owner | Buy | $500K (2,000,000 @ $0.25) |
| Apr 8, 2013 | BOCO Investments LLC | 10% Owner | Buy | $500K (2,000,000 @ $0.25) |
| Mar 6, 2013 | Steven Mark Bathgate | Director | Sell | $75K (300,000 @ $0.25) |
| Mar 6, 2013 | Vicki D E Barone | Director | Sell | $75K (300,000 @ $0.25) |
| Dec 26, 2012 | Steven Mark Bathgate | Director | Buy | $14K (47,355 @ $0.30) |
| Sep 7, 2012 | Steven Mark Bathgate | Director | Buy | $114K (100,000 @ $1.14) |
| Sep 7, 2012 | Vicki D E Barone | Director | Buy | $114K (100,000 @ $1.14) |
| Jun 27, 2011 | James D Crapo | CEO | Buy | $0 (40,000 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.